217 related articles for article (PubMed ID: 11089884)
1. Possible contribution of aminopeptidase N (APN/CD13) to invasive potential enhanced by interleukin-6 and soluble interleukin-6 receptor in human osteosarcoma cell lines.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 1999; 17(10):857-63. PubMed ID: 11089884
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
[TBL] [Abstract][Full Text] [Related]
3. Possible contribution of aminopeptidase N (APN/CD13) to migration and invasion of human osteosarcoma cell lines.
Liang W; Gao B; Xu G; Weng D; Xie M; Qian Y
Int J Oncol; 2014 Dec; 45(6):2475-85. PubMed ID: 25340499
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells.
Franchimont N; Lambert C; Huynen P; Ribbens C; Relic B; Chariot A; Bours V; Piette J; Merville MP; Malaise M
Arthritis Rheum; 2005 Jan; 52(1):84-93. PubMed ID: 15641051
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of the expression and the enzyme activity of aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 on human renal cell carcinoma cells and renal tubular epithelial cells by T cell-derived cytokines, such as IL-4 and IL-13.
Riemann D; Kehlen A; Langner J
Clin Exp Immunol; 1995 May; 100(2):277-83. PubMed ID: 7743667
[TBL] [Abstract][Full Text] [Related]
6. IL-10 and TGF-beta differ in their regulation of aminopeptidase N/CD13 expression in monocytes.
Kehlen A; Geisler M; Olsen J; Sablotzki A; Langner J; Riemann D
Int J Mol Med; 2004 Jun; 13(6):877-82. PubMed ID: 15138629
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor.
Van Wagoner NJ; Oh JW; Repovic P; Benveniste EN
J Neurosci; 1999 Jul; 19(13):5236-44. PubMed ID: 10377335
[TBL] [Abstract][Full Text] [Related]
8. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.
Hashizume M; Hayakawa N; Mihara M
Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta increases the expression of aminopeptidase N/CD13 mRNA and protein in monocytes and monocytic cell lines.
Kehlen A; Langner J; Riemann D
Adv Exp Med Biol; 2000; 477():49-56. PubMed ID: 10849730
[TBL] [Abstract][Full Text] [Related]
10. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells.
Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K
Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aminopeptidase N (EC 3.4.11.2; APN; CD13) by interferon-gamma on the HL-60 cell line.
Gabrilovac J; Breljak D; Cupić B; Ambriović-Ristov A
Life Sci; 2005 Apr; 76(23):2681-97. PubMed ID: 15792835
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-6 receptor (sIL-6R) makes IL-6R negative T cell line respond to IL-6; it inhibits TNF production.
Igaz P; Horváth A; Horváth B; Szalai C; Pállinger E; Rajnavölgyi E; Tóth S; Rose-John S; Falus A
Immunol Lett; 2000 Mar; 71(3):143-8. PubMed ID: 10722865
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression.
Oh JW; Van Wagoner NJ; Rose-John S; Benveniste EN
J Immunol; 1998 Nov; 161(9):4992-9. PubMed ID: 9794436
[TBL] [Abstract][Full Text] [Related]
14. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients.
Marie C; Losser MR; Fitting C; Kermarrec N; Payen D; Cavaillon JM
Am J Respir Crit Care Med; 1997 Nov; 156(5):1515-22. PubMed ID: 9372669
[TBL] [Abstract][Full Text] [Related]
15. The main neutral aminopeptidase activity of human lymphoid tumour cell lines does not originate from the aminopeptidase N-(APN; CD13) gene.
Wex T; Lendeckel U; Kähne T; Ittenson A; Frank K; Ansorge S
Biochim Biophys Acta; 1997 Feb; 1355(2):147-54. PubMed ID: 9042335
[TBL] [Abstract][Full Text] [Related]
16. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
17. Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R).
Lust JA; Jelinek DF; Donovan KA; Frederick LA; Huntley BK; Braaten JK; Maihle NJ
Curr Top Microbiol Immunol; 1995; 194():199-206. PubMed ID: 7895493
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex.
Ringheim GE; Szczepanik AM; Petko W; Burgher KL; Zhu SZ; Chao CC
Brain Res Mol Brain Res; 1998 Mar; 55(1):35-44. PubMed ID: 9645958
[TBL] [Abstract][Full Text] [Related]
19. TNF-alpha but not IL-1 and IL-6 modifies the susceptibility of human osteosarcoma cells to NK lysis.
Mariani E; Tarozzi A; Meneghetti A; Cattini L; Facchini A
Int J Oncol; 1998 Aug; 13(2):349-53. PubMed ID: 9664132
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
